1. Academic Validation
  2. Highlights in poloxamer-based drug delivery systems as strategy at local application for vaginal infections

Highlights in poloxamer-based drug delivery systems as strategy at local application for vaginal infections

  • Int J Pharm. 2021 Jun 1:602:120635. doi: 10.1016/j.ijpharm.2021.120635.
Gabriela Corrêa Carvalho 1 Victor Hugo Sousa Araujo 1 Bruno Fonseca-Santos 2 Jennifer Thayanne Cavalcante de Araújo 1 Maurício Palmeira Chaves de Souza 1 Jonatas Lobato Duarte 1 Marlus Chorilli 3
Affiliations

Affiliations

  • 1 School of Pharmaceutical Sciences, São Paulo State University (UNESP), 14800-903 Araraquara, Brazil.
  • 2 Faculty of Pharmaceutical Sciences, University of Campinas (UNICAMP), 13083-871 Campinas, Brazil.
  • 3 School of Pharmaceutical Sciences, São Paulo State University (UNESP), 14800-903 Araraquara, Brazil. Electronic address: marlus.chorilli@unesp.br.
Abstract

Infectious diseases related to the vagina include diseases caused by the imbalance of the vaginal flora and by sexually transmitted infections. Some of these present themselves as a public health problem due to the lack of efficient treatment that leads to their complete cure, and Others due to the growing resistance to drugs used in therapy. In this sense, new treatment strategies are desirable, with vaginal administration rout being a great choice since can bypass first-pass metabolism and decrease drug interactions and adverse effects. However, it is worth highlighting limitations related to patient's discomfort at application time. Thereby, the use of poloxamer-based drug delivery systems is desirable due its stimuli-sensitive characteristic. Therefore, the present review reports a brief overview of poloxamer properties, biological behavior and advances in poloxamer applications in controlled drug release systems for infectious diseases related to the vagina treatment and prevention.

Keywords

Biological behavior; Drug delivery; Infectious diseases; Poloxamer; Vaginal application.

Figures
Products